HR 4082
109th Congress
House
Taxation
Accounting
Biotechnology
Capital gains tax
Clinical trials
Commerce
Corporate debt
Corporate finance
Corporate mergers
Corporate reorganizations
Corporation taxes
Drug industry
Finance and Financial Sector
Health
Income tax
Investments
Losses
Pharmaceutical research
Science, Technology, Communications
Tax credits
Biotechnology Future Investment Expansion Act of 2005
Introduced: October 19, 2005
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 19, 2005
Referred to the House Committee on Ways and Means.
Oct 19, 2005
Introduced in House
Plain-English summary
Biotechnology Future Investment Expansion Act of 2005 - Amends the Internal Revenue Code to permit certain biomedical research corporations to engage in investments and other transactions involving shifts in ownership without incurring limitations on net operating loss carryforwards and certain built-in losses.
What's happening now
Referred to the House Committee on Ways and Means.
Committees of jurisdiction
1
Cosponsors
1